RIG
NVO

RiverFront Investment Group’s Novo Nordisk NVO Stock Holding History

RiverFront Investment Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,818
Closed -$202K – 127
2021
Q2 		$202K Buy
+4,818
New +$187K ﹤0.01% 140

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RiverFront Investment Group's NVO Position: Q3 2021 in Review

RiverFront Investment Group sold out of Novo Nordisk (NVO) in Q3 2021, closing a stake of 4,818 shares — an estimated $202K sold.

RiverFront Investment Group first reported a position in NVO in Q2 2021 and held it in 1 quarter. The position peaked at $202K in Q2 2021. 804 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

  • RiverFront Investment Group reported no remaining Novo Nordisk position as of Q3 2021 after selling out during the quarter.
  • RiverFront Investment Group sold 4,818 Novo Nordisk shares in Q3 2021, an estimated $202K.
  • RiverFront Investment Group first reported a position in Novo Nordisk in Q2 2021 and held it in 1 quarter.
  • RiverFront Investment Group's Novo Nordisk position peaked at $202K in Q2 2021.
  • 804 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on RiverFront Investment Group's 13F filing for Q3 2021, filed 2 Nov 2021.